Company Creation
We support and facilitate the creation of high-tech, innovative companies. We identify and 'spin-out' commercial and not-for-profit activities from our world class research.
Our company creation
We support and facilitate the creation of high-tech, innovative companies. We identify and 'spin-out' commercial and not-for-profit activities from our world class research.
You might want to invest or partnering with one of our companies. Or you might want to join as an experienced executive who can support a company's growth. If you're an investor, an adviser or an academic and interested in working with us and our portfolio of companies, please get in touch.
Spin-out companies
We have an excellent track record for producing spin-out companies from applied research. We also play a significant role in the development of new products and services.
Our spin-out companies contribute to the development and vitality of the region through new jobs and revenue creation.
Executives into business
We support our deep tech and innovative spin-out companies to maximize their growth and success. This may involve recruiting executives with a high level of business acumen and experience in scaling up businesses.
We want to attract ambitious, experienced, and well-networked business executives to early-stage ventures. We offer remuneration and equity. We are particularly looking for executives with experience in deep tech life sciences and engineering.
If you believe you have the skills and experience to lead a spin-out business, or want to find out more, get in touch.
Northern Accelerator
We are founding members of the Northern Accelerator programme. This is a collaboration between the universities in the North East of England. The programme has accelerated the commercialisation of innovation. It boosts our region’s economy, making a real-world impact from world-leading research.
Information for investors
Our spin-out companies are at the forefront of innovation. They transform groundbreaking ideas and discoveries into commercial, high growth propositions.
Whether angel, venture or institutional investing, we can present:
- early access to high-growth venture: engage with promising companies at the forefront of innovation
- robust due diligence and support: our experienced teams ensure transparency and strategic alignment of your aims and our spin-outs
- ongoing collaboration opportunities: build long-term partnerships with the University and its vibrant entrepreneurial network including our angel group
Our intellectual property policy is a public document. It outlines the support we offer to spin-out company creation and our founding equity position.
Investing in Newcastle University spin-outs is more than a financial opportunity. It’s a chance to be part of a transformative journey. Together, we can accelerate innovation, deliver impact, and create lasting value.
Digital, AI, engineering and environment
- Advanced Electric Machines - uniquely sustainable electric traction motors
- Armatus Oceanic - deep ocean science and consultancy
- APIX Nutrition - next generation beekeeping technology
- Dragonfly Insulation - patented silica aerogel manufacturing
- Indicatrix Crystallography - bespoke crystallisation screening for small organic molecules
- Literal Labs - artificial intelligence whose Logic-Based Networks (LBNs) deliver over to 50× faster inference with over 50× less energy use
- METzero - advanced wastewater treatment that saves energy, reduces emissions, and recovers valuable resources
- Microbritt - chip manufacturing using microfluidics
- Ocular Systems - 3D particle shape metrology and functional modelling platform
- Recovolt - battery safety and assessment
- Smartcoater
Medtech, biotech, health and life sciences
- Aelius Biotech - gut modelling to improve orally delivered products
- Alcyomics - non-artificial human invitro skin testing
- Atelerix - hypothermic gel technology stabilises biological samples at room temperature, cutting costs, simplifying logistics and protecting viability
- 3D Bio-Tissues - producing bio-equivalent tissues for clinical and cellular agriculture, applying novel bio-inspired manufacturing
- Demuris (Odyssey) - drug discovery for autoimmune and inflammatory diseases
- Enoda - real-world mobility monitoring to inform clinical trials
- ESP Diagnostics - solutions for minimally invasive diagnosis of neurodegenerative disorders
- FibroFind - preclinical CRO supporting drug development with liver, kidney and lung translational models
- GitLife - building the infrastructure for biological rights and IP management, helping biotech teams structure, protect, and commercialise their innovations from day one
- GlycoScore - patented blood test that has potential to revolutionise how prostate cancer is diagnosed
- Gnosis Health - build continuous, individualised care between appointments: longitudinal clinical intelligence for the conditions that quietly shape a life
- JawSpace - spin-in using clinical research, pain science, and intuitive design to make Temporomandibular disorder (TMD) self-management accessible
- JetBio - fast, flexible system for printing biomimetic cell filled gels for use in developing in vitro disease models for drug testing
- MarraBio - engineered Cytocaf proteins provide an easy to use, ultra stable, scalable and xeno-free alternative to the extracellular matrix proteins and growth factors used in mammalian cell culture
- Newcells Biotech - opthamology business acquired by Axol Bioscience to supply proprietary iPSC-derived products and ophthalmology research services
- NunaBio - high-complexity DNA constructs, from challenging sequences to production-scale material on a single deployable platform
- Sapien View
- ScubaTx - organ preservation through advanced hypothermic technology, giving transplant teams more time, better outcomes, and greater confidence
- Skin Life Analytics - world's first non-invasive skin swab
- Tangram Therapeutics (formerly eTherapeutics) - integrates computational power and biology to accelerate the discovery of life-transforming RNAi medicines
- TREAT-NMD - accelerating the development of effective treatments for neuromuscular diseases
- XR Therapeutics - mental healthcare using simulations for targeted therapy
Our team
We have extensive, hands on experience of creating and successfully managing new businesses. Our team includes:
- Rick McCordall, Head of Company Creation
- James Tetley, Company Creation Commercial Advisor
- Caitlin Jardine, Company Creation Administrator
If you would like to discuss any business opportunities with the team please contact contact Caitlin Jardine, our Company Creation Administrator.
